Circle Cardiovascular Imaging

Circle Cardiovascular Imaging develops and markets cardiovascular post-processing software for the evaluation of magnetic resonance imaging (MRI) and CT images. It offers cmr42, a cardiovascular post-processing software for viewing and analyzing cardiovascular MR (CMR) images; ct42, a cardiovascular post-processing software for viewing and analyzing CCT images; cvi42, an integrated cardiovascular post-processing software for viewing and analyzing CMR and CCT images; and report42, a software solution that facilitates the documentation and reporting of CMR and CCT images.

Circle Cardiovascular Imaging also provides product support, and training and education services for its software. Its software is used in the treatment of various indications, including heart failure, coronary artery disease, ischemic heart disease, myocardial infarction/scar, non-ischemic CM, myocarditis, valvular heart disease, cardiac masses, pericardial disease, pulmonary angiography, atrial fibrillation, carotid disease, and thoracic aortic disease. Its software is used by physicians and healthcare institutions in clinical and research settings.

Circle Cardiovascular Imaging markets its software through a network of distributors worldwide. Kelly Cherniwchan founded it in 2007, with its headquarters in Calgary in Canada.

Circle Cardiovascular Imaging headquartered in North America, operates in the Information Technology, Software, Health Care, Computer sector. The company focuses on Information Technology and has secured $1.6B in funding across 80 round(s). With a team of 11-50 employees, Circle Cardiovascular Imaging is actively contributing to advancements in Information Technology. Their latest funding round, Venture Round - Circle Cardiovascular Imaging, raised $3.9M. Discover more about their projects, partnerships, and impact on our platform.